FindTrial
Sign In

CLINICAL STUDY TO EVALUATE THE EFFICACY OF SUVARNAPRASHANA ON GROWTH & DEVELOPMENT ALONG WITH ITS EFFECT ON MORBIDITY STATUS IN 0-5 YEAR AGE CHILDREN

CLINICAL STUDY TO EVALUATE THE EFFICACY OF SUVARNAPRASHANA ON GROWTH AND DEVELOPMENT AND NUTRITION ALONG WITH ITS EFFECT ON MORBIDITY STATUS IN 0-5 YEAR AGE CHILDREN

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050249
Enrollment
200
Registered
2023-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

DR S R RAJASTHAN AYURVED UNIVERSITY
Lead Sponsor
DABUR INDIA LIMITED
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children of 0-5 year of age will be selected in study 2.Children having recurrent episodes of fever, running nose, cold, cough, abdominal pain, nausea, vomiting, loose stools, abdominal distension and constipation will be considered in the study.

Exclusion criteria

Exclusion criteria: 1.Children above 5 year of age will be excluded. 2.Children showing sign of delayed growth & development will be excluded in the study due to any organic lesion. 3.Children having hypersensitivity to gold, honey & ghrita will be excluded.

Design outcomes

Primary

MeasureTime frame
Improve growth and development and nutrition of children of 0 - 5 age group.Timepoint: 6 months—

Secondary

MeasureTime frame
Minimized the morbidity status in children of 0-5 year age group through Suvarnaprashana.Timepoint: 6 months—

Countries

India

Contacts

Public ContactProf Prem Prakash Vyas

DSRRAU

prjapati.pradeep1@gmail.com9818574845

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026